Atlas Trials

Mass Balance Study of TQB3616

Clinical trial NCT06149611 · UNKNOWN

Trial details

NCT number
NCT06149611
Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Breast Cancer
Start date
2024-01-01
Primary completion
2024-06-01
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.